Published in Brain on February 01, 2001
Paraneoplastic syndromes of the CNS. Lancet Neurol (2008) 4.62
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Paraneoplastic neurological syndromes. Orphanet J Rare Dis (2007) 2.32
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry (2012) 2.21
Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases. Eur J Pediatr (2009) 1.59
Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol (2004) 1.29
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol (2014) 1.25
Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol (2013) 1.15
Paraneoplastic neurological syndromes. Clin Exp Immunol (2014) 1.12
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood (2014) 1.06
Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies. J Neurol Neurosurg Psychiatry (2006) 0.99
Paraneoplastic and other autoimmune disorders of the central nervous system. Neurohospitalist (2013) 0.97
Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn) (2015) 0.90
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. J Neuroinflammation (2014) 0.90
Low level anti-Hu reactivity: A risk marker for small cell lung cancer? Cancer Detect Prev (2008) 0.88
Opsoclonus myoclonus. Innov Clin Neurosci (2011) 0.84
Opsoclonus-myoclonus as a manifestation of Lyme disease. J Neurol Neurosurg Psychiatry (2006) 0.80
Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol (2016) 0.78
Opsoclonus-Myoclonus syndrome. BMJ Case Rep (2011) 0.78
T-cell primary leptomeningeal lymphoma in cerebellopontine angle. BMJ Case Rep (2015) 0.78
Diagnostic value of nystagmus: spontaneous and induced ocular oscillations. J Neurol Neurosurg Psychiatry (2002) 0.77
Update on paraneoplastic neurologic disorders. Oncologist (2010) 0.77
IVIG therapy in neurological disorders of childhood. J Neurol (2006) 0.76
Opsoclonus myoclonus syndrome due to squamous cell carcinoma of the oesophagus. BMJ Case Rep (2014) 0.76
Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma. J Neurol (2008) 0.76
Opsoclonus-myoclonus syndrome associated with mumps virus infection. J Clin Neurol (2014) 0.75
Ocular flutter as the presenting sign of lung adenocarcinoma. Digit J Ophthalmol (2014) 0.75
Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature. J Pediatr Neurosci (2017) 0.75
'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma. BMJ Case Rep (2014) 0.75
Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer. Rare Tumors (2010) 0.75
The Production Processes and Biological Effects of Intravenous Immunoglobulin. Biomolecules (2016) 0.75
Opsoclonus-myoclonus syndrome in an adult with malignant melanoma. J Neurol (2006) 0.75
Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report. J Neurol (2016) 0.75
Rapid Resolution of Enterovirus 71-Associated Opsoclonus Myoclonus Syndrome on Intravenous Immunoglobulin. Child Neurol Open (2017) 0.75
Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion. J Neurol (2009) 0.75
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain (1997) 2.64
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology (2007) 2.00
Analysis of relapses in anti-NMDAR encephalitis. Neurology (2011) 1.98
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology (1997) 1.85
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82
Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology (2004) 1.81
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology (2003) 1.79
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology (2004) 1.77
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
[Prions and blood donation]. Med Clin (Barc) (2001) 1.72
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology (2011) 1.71
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol (2006) 1.67
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66
Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol (2012) 1.62
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry (2000) 1.59
Neurologic complications associated with hepatitis C virus infection. Neurology (1999) 1.58
Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49
Neuromodulation of the posterolateral hypothalamus for the treatment of chronic refractory cluster headache: Experience in five patients with a modified anatomical target. Cephalalgia (2011) 1.47
Mapping of Friedreich's ataxia locus by identification of recombination events in patients homozygous by descent. Eur J Hum Genet (1994) 1.47
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46
The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology (2010) 1.44
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
[Limb shaking and loss of consciousness: a carotid-basilar artery syndrome]. Neurologia (1995) 1.44
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39
[Spinal cord compression in cancer patients]. Med Clin (Barc) (1997) 1.39
Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer. Neurology (1998) 1.39
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
[Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy]. Nefrologia (2011) 1.38
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) (1988) 1.35
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology (2000) 1.28
Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology (1991) 1.26
Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich's ataxia locus on chromosome 9q. Ann Neurol (1995) 1.25
Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol (2005) 1.24
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun (2010) 1.22
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry (2008) 1.22
Central nervous system involvement in mantle cell lymphoma. Ann Oncol (2007) 1.22
Spectrum of paraneoplastic disease associated with lymphoma. Neurology (2011) 1.20
Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry (2006) 1.18
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol (2006) 1.17
Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke (1995) 1.17
Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.15
EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol (2010) 1.13
Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol (1999) 1.11
Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol (2002) 1.10
[Limbic encephalitis: a probably under-recognized syndrome]. Neurologia (2005) 1.10
Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology (2009) 1.09
Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology (2011) 1.08
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology (1993) 1.08
Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol Scand (1987) 1.07
Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet (1996) 1.06
CNS involvement in mantle-cell lymphoma. J Clin Oncol (1996) 1.05
Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology (2007) 1.03
Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry (1999) 1.03
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS (1990) 1.03
Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology (1999) 1.02
Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. J Neurol Neurosurg Psychiatry (2006) 1.02
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology (2004) 1.02
Collagen graft interposition in vesicovaginal fistula treatment. Urol Int (2009) 1.01
Partial Brown-Séquard's syndrome and meningococcal meningitis. Arch Neurol (1981) 1.00
Predictive factors of in-hospital CNS complications following liver transplantation. Neurology (1994) 0.99
Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci (2001) 0.99
Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol (2004) 0.96
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol (2007) 0.95
Relapsing neuromyelitis optica: long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry (2009) 0.95
Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler (2007) 0.95
Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry (2008) 0.94
Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler (2008) 0.93
Cerebral infarction of the basal ganglia due to embolism from the heart. Stroke (1984) 0.93
Hyperkalaemic paralysis, neuropathy and persistent motor neuron discharges at rest in Addison's disease. J Neurol Neurosurg Psychiatry (1980) 0.93
Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. Eur J Neurol (2014) 0.92
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial. Neurology (2004) 0.92
Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies. J Neurol Neurosurg Psychiatry (2009) 0.92